Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

Clinical trial NCT06866262 · RECRUITING

Trial details

NCT number: NCT06866262
Sponsor: University of Michigan Rogel Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Clear Cell Renal Cell Carcinoma Locally Advanced Sarcomatoid Renal Cell Carcinoma Metastatic Clear Cell Renal Cell Carcinoma Metastatic Sarcomatoid Renal Cell Carcinoma Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8

Start date: 2025-08-15
Primary completion: 2031-08-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.